[go: up one dir, main page]

WO1999061597A3 - Methodes et materiels ameliores de transformation - Google Patents

Methodes et materiels ameliores de transformation Download PDF

Info

Publication number
WO1999061597A3
WO1999061597A3 PCT/US1999/011250 US9911250W WO9961597A3 WO 1999061597 A3 WO1999061597 A3 WO 1999061597A3 US 9911250 W US9911250 W US 9911250W WO 9961597 A3 WO9961597 A3 WO 9961597A3
Authority
WO
WIPO (PCT)
Prior art keywords
transformation
expression cassette
suitable promoter
viral sequence
modified viral
Prior art date
Application number
PCT/US1999/011250
Other languages
English (en)
Other versions
WO1999061597A2 (fr
WO1999061597A9 (fr
Inventor
Lada Rasochova
Thomas L German
Paul G Ahlquist
Original Assignee
Wisconsin Alumni Res Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wisconsin Alumni Res Found filed Critical Wisconsin Alumni Res Found
Priority to BR9911065-2A priority Critical patent/BR9911065A/pt
Priority to EP99953356A priority patent/EP1086237A2/fr
Priority to JP2000550982A priority patent/JP3959965B2/ja
Priority to AU43101/99A priority patent/AU763096B2/en
Priority to CA002329509A priority patent/CA2329509C/fr
Publication of WO1999061597A2 publication Critical patent/WO1999061597A2/fr
Publication of WO1999061597A9 publication Critical patent/WO1999061597A9/fr
Publication of WO1999061597A3 publication Critical patent/WO1999061597A3/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8201—Methods for introducing genetic material into plant cells, e.g. DNA, RNA, stable or transient incorporation, tissue culture methods adapted for transformation
    • C12N15/8202—Methods for introducing genetic material into plant cells, e.g. DNA, RNA, stable or transient incorporation, tissue culture methods adapted for transformation by biological means, e.g. cell mediated or natural vector
    • C12N15/8203—Virus mediated transformation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8201—Methods for introducing genetic material into plant cells, e.g. DNA, RNA, stable or transient incorporation, tissue culture methods adapted for transformation
    • C12N15/8202—Methods for introducing genetic material into plant cells, e.g. DNA, RNA, stable or transient incorporation, tissue culture methods adapted for transformation by biological means, e.g. cell mediated or natural vector
    • C12N15/8205—Agrobacterium mediated transformation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8216—Methods for controlling, regulating or enhancing expression of transgenes in plant cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Virology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

L'invention concerne de nouvelles méthodes et de nouveaux matériels destinés à la transformation d'une cellule hôte et à l'expression dans celle-ci d'ARN exogène. Spécifiquement, l'invention concerne des plates-formes de lancement d'ADN utilisées pour introduire un segment viral réplicant fixé à un polynucléotide exogène dans une cellule, de manière que le polynucléotide exogène soit exprimé dans ladite cellule et confère un trait détectable.
PCT/US1999/011250 1998-05-22 1999-05-21 Methodes et materiels ameliores de transformation WO1999061597A2 (fr)

Priority Applications (5)

Application Number Priority Date Filing Date Title
BR9911065-2A BR9911065A (pt) 1998-05-22 1999-05-21 Processos melhorados e materiais para transformação
EP99953356A EP1086237A2 (fr) 1998-05-22 1999-05-21 Methodes et materiels ameliores de transformation
JP2000550982A JP3959965B2 (ja) 1998-05-22 1999-05-21 形質転換のための改良された方法および材料
AU43101/99A AU763096B2 (en) 1998-05-22 1999-05-21 Improved methods and materials for transformation
CA002329509A CA2329509C (fr) 1998-05-22 1999-05-21 Methodes et materiels ameliores de transformation

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8652698P 1998-05-22 1998-05-22
US60/086,526 1998-05-22

Publications (3)

Publication Number Publication Date
WO1999061597A2 WO1999061597A2 (fr) 1999-12-02
WO1999061597A9 WO1999061597A9 (fr) 2000-02-24
WO1999061597A3 true WO1999061597A3 (fr) 2000-03-30

Family

ID=22199163

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1999/011250 WO1999061597A2 (fr) 1998-05-22 1999-05-21 Methodes et materiels ameliores de transformation

Country Status (7)

Country Link
EP (1) EP1086237A2 (fr)
JP (1) JP3959965B2 (fr)
AR (1) AR020324A1 (fr)
AU (1) AU763096B2 (fr)
BR (1) BR9911065A (fr)
CA (1) CA2329509C (fr)
WO (1) WO1999061597A2 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0007231D0 (en) * 2000-03-24 2000-05-17 Chiron Spa Modified rna for gene delivery
US6800748B2 (en) * 2001-01-25 2004-10-05 Large Scale Biology Corporation Cytoplasmic inhibition of gene expression and expression of a foreign protein in a monocot plant by a plant viral vector
EP2192172B1 (fr) 2003-02-03 2014-12-03 iBio, Inc. Système d'expression de gènes chez les plantes
US8507220B2 (en) 2003-10-01 2013-08-13 Japan Science And Technology Agency Tobacco BY2 cells containing a tomato mosaic virus vector for protein production

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0194809A1 (fr) * 1985-03-07 1986-09-17 Lubrizol Genetics Inc. Vecteur de transformation d'ARN
WO1990012107A1 (fr) * 1989-03-31 1990-10-18 The Salk Institute Biotechnology/Industrial Associates, Inc. Systeme d'expression par recombinaison base sur le virus de la mosaique du tabac satellitaire
AU7195191A (en) * 1990-09-07 1992-03-12 Nihon Nohyaku Co., Ltd. Process for production of exogenous gene or its product in plant cells
WO1995007994A2 (fr) * 1993-09-15 1995-03-23 Viagene, Inc. Vecteurs composes d'alphavirus recombinants
WO1998036083A1 (fr) * 1997-02-14 1998-08-20 Plant Bioscience Limited Procedes et moyens de blocage de gene dans des plantes transgeniques

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0194809A1 (fr) * 1985-03-07 1986-09-17 Lubrizol Genetics Inc. Vecteur de transformation d'ARN
WO1990012107A1 (fr) * 1989-03-31 1990-10-18 The Salk Institute Biotechnology/Industrial Associates, Inc. Systeme d'expression par recombinaison base sur le virus de la mosaique du tabac satellitaire
AU7195191A (en) * 1990-09-07 1992-03-12 Nihon Nohyaku Co., Ltd. Process for production of exogenous gene or its product in plant cells
WO1995007994A2 (fr) * 1993-09-15 1995-03-23 Viagene, Inc. Vecteurs composes d'alphavirus recombinants
WO1998036083A1 (fr) * 1997-02-14 1998-08-20 Plant Bioscience Limited Procedes et moyens de blocage de gene dans des plantes transgeniques

Also Published As

Publication number Publication date
AU763096B2 (en) 2003-07-10
WO1999061597A2 (fr) 1999-12-02
JP2002516089A (ja) 2002-06-04
AU4310199A (en) 1999-12-13
AR020324A1 (es) 2002-05-08
CA2329509C (fr) 2009-10-06
BR9911065A (pt) 2001-02-06
JP3959965B2 (ja) 2007-08-15
EP1086237A2 (fr) 2001-03-28
WO1999061597A9 (fr) 2000-02-24
CA2329509A1 (fr) 1999-12-02

Similar Documents

Publication Publication Date Title
WO1999012950A3 (fr) Perfectionnements se rapportant a la stabilite des amidons des vegetaux
ATE368746T1 (de) L-rhamnose-induzierbare expressionssysteme
CA2195303A1 (fr) Procede de selection de cellules hotes a haut niveau d'expression
CA2185712A1 (fr) Transfert d'adn par mediation virale renforcee
PL1824977T3 (pl) Promotorowy kwas nukleinowy pochodzący z rodzaju Corynebacterium, kaseta ekspresyjna zawierająca promotor i wektor, komórka gospodarza zawierająca wektor i sposób ekspresji genu z użyciem komórki
EP0164556A3 (en) Enhanced yeast transcription employing hybrid promoter region constructs
AU4200897A (en) Novel host cells and methods of producing proteins
WO2005039501A3 (fr) Composition immunogene et procede d'elaboration d'un vaccin a base de proteine de fusion
EP0945515A3 (fr) Production de protéines par recombinaison homologue
WO1998014602A3 (fr) Preparation d'acides amines d par des materiaux et des procedes de fermentation directe
WO2001093212A3 (fr) Appareil et procedes pour utiliser une carte intelligente virtuelle
WO2005061716A3 (fr) Vecteur d'expression et son utilisation
WO2000053729A3 (fr) Particules virales liberees apres infection par le virus cytomegalique humain et leur utilisation comme vaccin
WO2000077233A3 (fr) Virus d'adn non mammalien resistant au complement et utilisations de ces virus
WO2004044161A3 (fr) Expression de sequences etrangeres dans des vegetaux utilisant un systeme de transactivation
IE840258L (en) Expression of gene products.
WO2003093409A3 (fr) Promoteurs presentant une specificite pour les cellules endotheliales et methodes d'utilisation correspondante
AU4940096A (en) Host cell expressing reduced levels of a metalloprotease and methods using the host cell in protein production
ATE454039T1 (de) Verfharen zur herstellung von herpes-simplex- virus-amplikons, die resultierenden amplikons und ihre verwendung
WO1999061597A3 (fr) Methodes et materiels ameliores de transformation
WO1994028125A3 (fr) Adn codant pour des recepteurs de prostaglandines
WO1999007735A3 (fr) Expression recombinee du peptide c de l'insuline
AU5961596A (en) Method for expression and isolation of biologically active m olecules in urine
EP0132309A3 (fr) Elément promoteur eucaryotique réglable
WO2001052042A3 (fr) Support d'enregistrement enregistre par un programme qui effectue un traitement en fonction d'une pluralite de sorties a partir d'un dispositif sensible a la pression, ordinateur executant le traitement et procede d'utilisation correspondant

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AL AU BA BB BG BR CA CN CU CZ EE GD GE HR HU ID IL IN IS JP KP KR LC LK LR LT LV MG MK MN MX NO NZ PL RO SG SI SK SL TR TT UA UZ VN YU ZA

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW SD SL SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: C2

Designated state(s): AE AL AU BA BB BG BR CA CN CU CZ EE GD GE HR HU ID IL IN IS JP KP KR LC LK LR LT LV MG MK MN MX NO NZ PL RO SG SI SK SL TR TT UA UZ VN YU ZA

AL Designated countries for regional patents

Kind code of ref document: C2

Designated state(s): GH GM KE LS MW SD SL SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

COP Corrected version of pamphlet

Free format text: PAGES 1/22-22/22, DRAWINGS, REPLACED BY NEW PAGES 1/20-20/20; DUE TO LATE TRANSMITTAL BY THE RECEIVING OFFICE

AK Designated states

Kind code of ref document: A3

Designated state(s): AE AL AU BA BB BG BR CA CN CU CZ EE GD GE HR HU ID IL IN IS JP KP KR LC LK LR LT LV MG MK MN MX NO NZ PL RO SG SI SK SL TR TT UA UZ VN YU ZA

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW SD SL SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

WWE Wipo information: entry into national phase

Ref document number: 1999953356

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 43101/99

Country of ref document: AU

ENP Entry into the national phase

Ref document number: 2000 550982

Country of ref document: JP

Kind code of ref document: A

Ref document number: 2329509

Country of ref document: CA

NENP Non-entry into the national phase

Ref country code: KR

WWP Wipo information: published in national office

Ref document number: 1999953356

Country of ref document: EP

WWG Wipo information: grant in national office

Ref document number: 43101/99

Country of ref document: AU